ArticleDiabetes, obesity & metabolism2017

Exenatide once weekly improved 24-hour glucose control and reduced glycaemic variability in metformin-treated participants with type 2 diabetes: a randomized, placebo-controlled trial.

Juan P Frías et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.